December 1, 2016
Via: CNBCShares of Valeant Pharmaceuticals fell nearly 8 percent Wednesday after a report said the company’s talks to sell its stomach-drug unit to Japan’s Takeda Pharmaceutical have fallen apart. Takeda’s shares were down about 1 percent in Tokyo trading Wednesday after […]